The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evolution of systemic therapy from 2015 to 2019 for older patients in the United States with metastatic renal cell carcinoma.
 
Ryan Dz-Wei Chow
Patents, Royalties, Other Intellectual Property - Patents pending related to methods for tumor immunology and cancer genomics
 
Jessica B. Long
No Relationships to Disclose
 
Sirad Hassan
No Relationships to Disclose
 
Stephanie B. Wheeler
Research Funding - Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Lisa Spees
Research Funding - AstraZeneca/Merck
 
Michael Leapman
No Relationships to Disclose
 
Michael E. Hurwitz
Employment - Arvinas (I); Gamida Cell (I); Pfizer (I)
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; crispr therapeutics; Exelixis; Janssen; Nektar
Research Funding - Achilles Therapeutics; Apexigen; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; Endocyte; Endocyte; Genentech; Genmab; Innocrin Pharma; Iovance Biotherapeutics; Lilly; Merck; Nektar; Novartis; Novartis; Pfizer; Progenics; Sanofi/Aventis; Seagen; Torque; Unum Therapeutics
 
Hannah Dzimitrowicz McManus
Research Funding - Pfizer (Inst)
 
Cary Philip Gross
Research Funding - AstraZeneca (Inst); Genentech; Johnson & Johnson (Inst)
 
Michaela Ann Dinan
Research Funding - AstraZeneca (Inst); Janssen (I)